A Real-Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down Syndrome.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Moltrasio Chiara, Sarno Luisa, Genovese Giovanni, Derlino Federica, Malvaso Dalma, Gaspari Valeria, Venturini Marina, Repetto Federica, Avallone Gianluca, Ribero Simone, Molinelli Elisa, Simonetti Oriana, Michelucci Alessandra, Romanelli Marco, Dini Valentina, Manfredini Marco, Magnoni Cristina, Foti Caterina, Sanna Silvia, Atzori Laura, Bardazzi Federico, Balestri Riccardo, Rech Giulia, Gisondi Paolo, Caro Raffaele Dante Caposiena, Zalaudek Iris, Lora Viviana, Fania Luca, Rosi Elia, Buffon Stefano, Maronese Carlo Alberto, Cartocci Alessandra, Rubegni Pietro, Prignano Francesca, Marzano Angelo Valerio
Аннотация
OBJECTIVES: Our aim was to describe the epidemiological and clinical features of patients with HS and concomitant DS in a relevant Italian cohort.
METHODS: We conducted a real-life, multicentre, retrospective, and descriptive analysis of 70 HS-DS patients with 2-year follow-up.
RESULTS: Seventy Caucasian adult patients (31 males and 39 females) affected by HS and DS were enrolled, with a mean age at baseline of 23.9 years. Mean body mass index (BMI) was 27.5 with obesity found in 20.9% of patients. Mean age at HS onset was 15.2, while at diagnosis was 18.6 with a diagnostic delay of 3.4 years. The groin was the most frequently involved site at HS onset and diagnosis, while the most common HS phenotype was the follicular one. At HS diagnosis, Hurley stage II was the most frequent with a median value of the International Hidradenitis Suppurativa Severity Score (IHS4) of 6 (moderate HS) while the most common therapy prescribed was systemic antibiotics, followed by topical treatments. Over follow-up, treatment patterns changed and IHS4, Dermatology Life Quality Index (DLQI) and pain numeric rating scale (NRS pain) scores decreased.
CONCLUSIONS: Our patient cohort is characterized by female predominance, high BMI, early HS onset, predominance of follicular phenotype, and moderate disease severity. Given the recognized association between these two conditions, we recommend regular screening by pediatricians and dermatologists for early detection and management of HS in DS patients. Future comparative studies are needed to clarify which features may be specifically associated with HS and concomitant DS.